Delivery Order SPE2DB25D3012-SPE2DB25FWZZV
Award Date 9/12/25
Potential Completion Date 10/3/25
Potential Value $43K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xalkori 250 mg capsules (60-count units) with a ceiling value of $14,356.89. This firm fixed-price delivery order, which must be completed by September 8, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $12,877.79 firm-fixed price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4565262000 XALKORI 250 MG CAPSULE 60S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to military treatment facilities worldwide....
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp for 60 capsules of Xalkori 200 mg, a targeted cancer therapy medication. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with completion anticipated by August 11, 2025. The contract carries no set-aside designation and represents a routine pharmaceutical procurement supporting federal military and healthcare system requirements. This delivery order is issued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,356.89 firm fixed-price contract is for the delivery of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $14,356.89 firm fixed price contract is for the delivery of XALKORI 250 MG CAPSULE 60S, with a performance period through June 2025. The contract is not set aside and allows for the provision of a wide range of pharmaceutical and medical products to support military healthcare programs....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XALKORI 250 MG CAPSULE 60S. The contract has a ceiling value of $12,877.79 and is a firm fixed price delivery order. The ultimate completion date for this contract is October 21, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
- This is a firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of XALKORI 250 MG CAPSULE 60S. The contract has a ceiling value of $14,356.89 and a performance period extending through August 5, 2025. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 4,565,470 units of the prescription drug XALKORI 250 MG CAPSULE 60S, with a ceiling value of $12,877.79. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies for the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $12,865.21 firm-fixed-price contract is for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, to support federal healthcare programs. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,356.89 and is for the supply of XALKORI 250 MG CAPSULE 60S, a prescription medication. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...